News from Cepheid A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 03, 2016, 16:05 ET

Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...

Feb 02, 2016, 16:02 ET

Cepheid Reports Fourth Quarter And Full Year 2015 Results

Cepheid (Nasdaq: CPHD) today reported revenue for the fourth quarter of 2015 of $147.0 million, representing growth of 12% from $131.5 million for...

Jan 13, 2016, 16:05 ET

Cepheid Announces Diagnostic Collaboration With MedImmune And COMBACTE To Facilitate Clinical Trials Of New Monoclonal Antibodies To Prevent Serious Infectious Diseases

 Cepheid (Nasdaq: CPHD) today announced a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, and...

Jan 11, 2016, 08:00 ET

Cepheid Schedules 2015 Fourth Quarter And Full Year Results Announcement And Webcast

 Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2015 fourth quarter and full year ended December 31, 2015...

Jan 07, 2016, 08:00 ET

USAID And Cepheid Plan Collaboration To Accelerate Global Diagnosis Of Multidrug-Resistant Tuberculosis

 Cepheid (NASDAQ: CPHD) today announced that it has signed a Memorandum of Understanding (MOU) representing the intention of the company,...

Jan 05, 2016, 08:00 ET

Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...

Jan 04, 2016, 08:00 ET

Cepheid Announces Distribution Agreement with Henry Schein

 Cepheid (NASDAQ: CPHD) today announced an agreement with Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc., for the...

Dec 08, 2015, 08:00 ET

Cepheid Announces International Commercial Availability Of Next Generation BCR-ABL Test

Cepheid (Nasdaq: CPHD) today announced the commercial availability outside the United States of Xpert® BCR-ABL Ultra, a quantitative measure...

Dec 07, 2015, 08:00 ET

Cepheid Receives FDA CLIA Waiver for Xpert Flu+RSV Xpress Test

 Cepheid (Nasdaq: CPHD) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory...

Dec 03, 2015, 08:03 ET

FIND And Cepheid Announce A Strategic Collaboration To Advance Point-Of-Care TB Diagnosis

FIND and Cepheid (Nasdaq: CPHD) today announced that they are broadening their collaboration on bringing point-of-care tuberculosis (TB) diagnosis...

Dec 01, 2015, 08:05 ET

Cepheid Commemorates World AIDS Day

 Cepheid (Nasdaq: CPHD) today announced that it had been named as a supplier of HIV Viral Load and early infant diagnostics by the Global Fund...

Dec 01, 2015, 08:03 ET

Cepheid Reaffirms 2015 Outlook At Piper Jaffray Healthcare Conference

Cepheid (Nasdaq: CPHD) today announced that, as part of its participation at the Piper Jaffray Healthcare Conference in New York City later this...

Nov 24, 2015, 16:05 ET

Cepheid to Webcast Upcoming Financial Presentation

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conference, and invited investors to participate via...

Nov 16, 2015, 08:00 ET

Cepheid Supports Inaugural Antibiotic Awareness Week

 Cepheid (Nasdaq: CPHD) today announced its support of World Antibiotic Awareness Week, a global campaign led by the World Health Organization...

Oct 20, 2015, 16:05 ET

Cepheid Reports 2015 Third Quarter Results

 Cepheid (Nasdaq: CPHD) today reported revenue for the third quarter of 2015 of $126.5 million, representing growth of 10% from $115.2 million...

Oct 13, 2015, 16:03 ET

Cepheid Reports Preliminary Results For 2015 Third Quarter

 Cepheid (Nasdaq: CPHD) today announced preliminary results for the quarter ending September 30, 2015. Based on Cepheid's preliminary...

Aug 13, 2015, 16:03 ET

Cepheid Announces CFO Change

Cepheid (Nasdaq: CPHD) today announced the departure of Ilan Daskal who held the position of Executive Vice President, Chief Financial Officer....

Aug 06, 2015, 16:05 ET

Cepheid to Webcast Upcoming Financial Presentations

 Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate...

Jul 29, 2015, 07:03 ET

'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms

 Cepheid (Nasdaq: CPHD) today announced the international availability of an update to Xpert® Carba-R, with the addition of two newly...

Jul 28, 2015, 07:05 ET
Cepheid's GeneXpert Omni for Point of Care

World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC

 Cepheid (Nasdaq: CPHD) today unveiled the GeneXpert® Omni, a flexible and portable clinical molecular diagnostic system designed to meet...